Founded in 2015 by Professor Andrew Mearns Spragg, a Scottish marine biotechnology pioneer, Jellagen is a marine biotechnology company manufacturing Collagen Type 0 for medical and scientific research applications. It is our deep belief in building sustainable sources for critical biomaterials which do not carry the environmental and human health risks of traditional collagen sources.
Since 2015, Jellagen has honed its proprietary technology, enhanced its product range, and extended its expertise.
Today Jellagen is led by a world-class team with experience across pharma, biotech, medical devices and investment banking. They bring strong scientific, clinical, and market development along with excellent commercial and business expertise. View the full Jellagen Team, Management Team, Board and Scientific Advisory Board here.
We know that to create smart and practical innovation we need to harness the knowledge and experience of the best in the world. We collaborate with universities, research laboratories and medical companies both big and small to create solutions that build on knowledge and deliver step changes in the application of collagen.
Our collaborators include: